drugset / Trial / NCT01641900

Effects of Eszopiclone on Sleep and Memory in Schizophrenia

NCT01641900

RandomizedCrossoverQuadruple-blindTreatment

Summary

The investigators will test the hypothesis that the sleep medication, eszopiclone, can normalize brain activity during sleep and improve memory in patients with schizophrenia. The investigators will do this by measuring sleep and memory performance on two conditions separated by one week: taking 3 mg of eszopiclone and taking placebo. The investigators will study healthy subjects and chronic, medicated outpatients with schizophrenia.

Timeline

Start
2012-07
Primary completion
2015-12
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Eszopiclone Small molecule 3 mg

Indications